First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5- fluorouracil (DCF) plus panitumumab (P) in patients with locally advanced or metastatic cancer of the stomach or gastro-esophageal junction
Latest Information Update: 15 Jul 2015
At a glance
- Drugs Panitumumab (Primary) ; Cisplatin; Docetaxel; Fluorouracil; Folinic acid
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 15 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.